Transgenomic Eyes Dana-Farber's COLD-PCR for Cancer Screening Applications

COLD-PCR preferentially amplifies segments of DNA that contain mutations, and is thereby able to increase the sensitivity of downstream mutation-detection methods by a factor of 10 to 100. Transgenomic believes it can increase the sensitivity of the approach even further in order to detect low-concentration mutations in the blood that could serve as early indicators of cancer.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register quickly here for free access.